Huapont Life Sciences Co.,Ltd. (SHE: 002004)

Huapont Life Sciences Co.,Ltd. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021	Dec 31, 2019
Cash & Equivalents	3,640	3,783	4,187	4,386	4,122	3,366
Short-Term Investments	-	1,197	799.5	605.52	-	638.2
Trading Asset Securities	595.85	630.28	706.29	1,030	862.27	684.89
Cash & Short-Term Investments	4,236	5,610	5,692	6,022	4,985	4,690
Cash Growth	-3.79%	-1.44%	-5.48%	20.81%	6.29%	-15.76%
Accounts Receivable	2,861	2,048	2,294	2,676	2,196	2,317
Other Receivables	701.92	681.23	583.37	666.99	401.89	474.49
Receivables	3,563	2,729	2,877	3,343	2,598	2,791
Inventory	2,364	2,675	2,536	2,402	1,951	2,092
Prepaid Expenses	-	9.24	3.88	14.94	-	31.93
Other Current Assets	1,626	364.53	445.45	531.85	1,269	454.01
Total Current Assets	11,789	11,387	11,554	12,314	10,803	10,059
Property, Plant & Equipment	10,088	10,051	8,920	7,973	7,922	7,128
Long-Term Investments	2,683	2,884	2,940	2,534	2,605	2,490
Goodwill	2,740	2,740	2,948	3,440	3,465	3,465
Other Intangible Assets	1,544	1,599	1,733	1,724	1,643	1,459
Long-Term Deferred Tax Assets	513.87	434.04	342.15	266.23	354.99	338.77
Long-Term Deferred Charges	578.76	540.53	558.56	570.14	323.71	693.39
Other Long-Term Assets	1,126	1,092	1,033	1,218	1,147	1,003
Total Assets	31,063	30,727	30,029	30,040	28,263	26,636
Accounts Payable	2,312	2,703	2,375	2,439	1,759	1,528
Accrued Expenses	182.85	1,704	1,728	1,556	329.25	1,183
Short-Term Debt	4,018	4,666	4,576	5,493	7,409	6,078
Current Portion of Long-Term Debt	1,902	1,016	1,678	1,192	-	1,531
Current Portion of Leases	-	12.62	9.52	9.44	-	-
Current Income Taxes Payable	268.84	121.68	245.78	170.38	125.24	129.43
Current Unearned Revenue	169.52	201.39	304.6	383.17	284.55	-
Other Current Liabilities	1,735	210.42	193.96	146.13	1,816	511.73
Total Current Liabilities	10,588	10,634	11,112	11,389	11,723	10,960
Long-Term Debt	3,419	2,884	1,742	2,222	1,839	2,014
Long-Term Leases	50.41	47.62	41.9	51.62	34.87	-
Long-Term Unearned Revenue	250.65	271.23	278.21	258.13	224.94	152.72
Long-Term Deferred Tax Liabilities	105.97	111.64	109.84	103.4	108.31	115.6
Other Long-Term Liabilities	193.86	193.95	194.63	196.68	196.8	150.42
Total Liabilities	14,608	14,143	13,478	14,221	14,126	13,393
Common Stock	1,980	1,980	1,980	1,980	1,980	1,980
Additional Paid-In Capital	5,337	5,290	5,249	5,214	4,885	4,680
Retained Earnings	2,937	2,920	3,050	3,089	2,857	2,641
Treasury Stock	-29.5	-	-	-	-	-
Comprehensive Income & Other	-114.7	-84.95	-87.55	-176.15	-92.77	39.77
Total Common Equity	10,109	10,105	10,192	10,107	9,629	9,341
Minority Interest	6,346	6,480	6,359	5,712	4,507	3,903
Shareholders' Equity	16,455	16,585	16,551	15,819	14,137	13,244
Total Liabilities & Equity	31,063	30,727	30,029	30,040	28,263	26,636
Total Debt	9,389	8,626	8,048	8,968	9,283	9,622
Net Cash (Debt)	-5,153	-3,016	-2,355	-2,946	-4,298	-4,932
Net Cash Per Share	-2.61	-1.52	-1.19	-1.49	-2.18	-2.47
Filing Date Shares Outstanding	1,973	1,976	1,980	1,980	1,980	1,980
Total Common Shares Outstanding	1,973	1,980	1,980	1,980	1,980	1,980
Working Capital	1,200	753.65	442.59	924.82	-919.78	-901.46
Book Value Per Share	5.12	5.10	5.15	5.10	4.86	4.72
Tangible Book Value	5,825	5,766	5,511	4,943	4,522	4,417
Tangible Book Value Per Share	2.95	2.91	2.78	2.50	2.28	2.23
Buildings	-	5,626	5,120	4,570	4,509	4,152
Machinery	-	7,632	6,765	6,051	5,492	4,940
Construction In Progress	-	1,869	1,434	1,464	1,532	1,718

Source: S&P Capital IQ. Standard template. Financial Sources.